Literature DB >> 11054725

Differential expression of laminin chains and anti-laminin autoantibodies in experimental lupus nephritis.

C J Peutz-Kootstra1, K Hansen, E De Heer, C K Abrass, J A Bruijn.   

Abstract

Mice with chronic graft-versus-host disease (GvHD) develop a lupus-like disease with severe immune complex glomerulonephritis. Previous studies with this model have shown that anti-laminin autoantibodies are involved in immune complex formation and that glomerular laminin expression alters qualitatively. The present study investigated glomerular laminin chain expression and autoantibody reactivity with matrix antigens during disease development in mice with chronic GvHD, killed before and 6, 8, 10, and 11 weeks after disease induction, using antibodies raised against laminin chain peptides, in immunofluorescence and western blotting studies. Decreased glomerular expression of the laminin beta1 chain, unaltered expression of the laminin beta2 and gamma1 chains, and increased expression of the laminin alpha1 chain and filamin/actin-binding protein 280 (ABP 280) were found during disease progression. Furthermore, 4 weeks after disease induction, autoantibodies appeared which were reactive with laminin alpha1, beta1, beta2, and gamma1 chains, and filamin in rat mesangial cell matrix. Ten weeks after disease induction, autoantibodies reacted with filamin, and beta2 and gamma1 laminin chains. Autoantibodies reacted with laminin chains only and not with other proteins in matrices extracted from glomeruli of normal and diseased mice. Staining with H50, an anti-laminin alpha1 chain/anti-filamin monoclonal autoantibody derived from an MRL/lpr mouse with spontaneous lupus nephritis, confirmed these observations and showed identical anti-laminin/anti-filamin autoantibody reactivity in two different models for lupus nephritis. In summary, differential glomerular expression of laminin chains was found during the development of chronic GvHD. Concomitantly with expression of the laminin alpha1 chain and/or filamin in the glomerulus, anti-laminin alpha1 and/or anti-filamin reactivity was present, pointing towards a role for (neo) antigen expression in the epitope spreading of the immune response. Furthermore, glomerular expression of laminin beta1 decreased in conjunction with decreased presence of anti-laminin beta1 reactivity, presumably due to antigen masking or shedding of immune complexes into the urine. These changes in anti-laminin chain autoantibodies, with concomitant alterations in the glomerular expression of laminin chains, may aggravate progressive immune injury in this model for lupus nephritis. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054725     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH707>3.0.CO;2-L

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

Review 1.  The integrin-actin connection, an eternal love affair.

Authors:  Cord Brakebusch; Reinhard Fässler
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

2.  Possible role of autoantibodies against nephrin in an experimental model of chronic graft-versus-host disease.

Authors:  K Nagahama; K Maru; S Kanzaki; H L Chai; T Nakai; S Miura; A Yamaguchi; S Yamanaka; Y Nagashima; I Aoki
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  Expression, crystallization and preliminary crystallographic data analysis of filamin A repeats 14-16.

Authors:  Adeleke Halilu Aguda; Amos Malle Sakwe; Lars Rask; Robert Charles Robinson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-03-12

Review 4.  Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Authors:  Geoffrey D E Cuvelier; Michelle Schoettler; Nataliya P Buxbaum; Iago Pinal-Fernandez; Marc Schmalzing; Jörg H W Distler; Olaf Penack; Bianca D Santomasso; Robert Zeiser; Klemens Angstwurm; Kelli P A MacDonald; W Taylor Kimberly; Naomi Taylor; Ervina Bilic; Bernhard Banas; Maike Buettner-Herold; Namita Sinha; Hildegard T Greinix; Joseph Pidala; Kirk R Schultz; Kirsten M Williams; Yoshihiro Inamoto; Corey Cutler; Linda M Griffith; Stephanie J Lee; Stefanie Sarantopoulos; Steven Z Pavletic; Daniel Wolff
Journal:  Transplant Cell Ther       Date:  2022-05-31

5.  Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux.

Authors:  Anna Sabasiñska; Walentyna Zoch-Zwierz; Anna Wasilewska; Tadeusz Porowski
Journal:  Pediatr Nephrol       Date:  2008-02-21       Impact factor: 3.714

6.  Laminin α1 regulates age-related mesangial cell proliferation and mesangial matrix accumulation through the TGF-β pathway.

Authors:  Liang Ning; Hidetake Kurihara; Susana de Vega; Naoki Ichikawa-Tomikawa; Zhuo Xu; Risa Nonaka; Saiko Kazuno; Yoshihiko Yamada; Jeffrey H Miner; Eri Arikawa-Hirasawa
Journal:  Am J Pathol       Date:  2014-04-08       Impact factor: 4.307

7.  Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor.

Authors:  Christine K Abrass; Kim M Hansen; Bruce L Patton
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

8.  Increased risk of systemic lupus erythematosus in pregnancy-induced hypertension: A nationwide population-based retrospective cohort study.

Authors:  Li-Te Lin; Peng-Hui Wang; Kuan-Hao Tsui; Jiin-Tsuey Cheng; Jin-Shiung Cheng; Wei-Chun Huang; Pei-Ling Tang; Li-Yu Hu
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 9.  Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.

Authors:  Anders Tveita; Ole Petter Rekvig; Svetlana N Zykova
Journal:  Arthritis Res Ther       Date:  2008-12-01       Impact factor: 5.156

10.  A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.

Authors:  Julia Y Wang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  bioRxiv       Date:  2021-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.